Biotech Startups

The Pennycress Company develops pennycress oil as a renewable fuel feedstock for biodiesel, renewable diesel, and sustainable aviation fuel production. Grown as a winter annual on fallow farmland, the feedstock avoids crop displacement while reducing lifecycle greenhouse gas emissions and qualifies for government low-carbon fuel incentive programs.

1 investor

The Protein Brewery develops FERMOTEIN, a fermentation-based whole food ingredient made from fungal mycelium that provides complete protein and prebiotic fiber. The product targets the alternative protein and nutrition market as a plant-based, non-GMO food ingredient.

1 investor

Ritedose is a contract development and manufacturing organization (CDMO) that produces generic and specialty medications using advanced data analysis and custom technology solutions. The company serves patients and pharmaceutical clients by manufacturing high-quality drugs in cGMP-compliant facilities while maintaining a focus on safety, quality, and environmental sustainability.

1 investor

The Siesta Group provides computer-assisted sleep scoring and EEG biomarker extraction services, with AI-powered analysis of biometric signals for pharmaceutical and biotechnology firms. The company supports clinical trials focused on neurology therapies through centralized scoring and proprietary biomarker research tools.

1 investor

TheiaNova is developing a non-surgical therapy to induce remodeling of the cornea for patients with ectatic vision disorders such as keratoconus. The company, spun out of research at the University of Auckland's Department of Ophthalmology, is a biotech working to bring this corneal therapeutic agent to the clinic.

1 investor

MRN operates a decentralized clinical trial site network that connects trial sponsors with diverse patient populations through flexible, community-based delivery models. The platform provides participating sites with eClinical technology, staffing support, and project management to enable faster patient recruitment and retention across traditional, hybrid, and remote trial settings.

1 investor

A venture capital or advisory firm with partners across Europe, the US, and Asia who provide mentorship and investment guidance to startups in cloud, AI, and deeptech sectors.

1 investor

Theodorus is a Belgian seed-stage venture capital firm that invests in and supports researchers and entrepreneurs building science-based companies. It manages four funds totaling €70M and focuses on financing innovative research spin-offs, particularly in life sciences and deep tech.

1 investor

Theora partners with Indian healthcare organizations to aggregate, structure, and de-identify clinical and genomic data for pharmaceutical and AI research, addressing the underrepresentation of Indian populations in drug discovery and genetic studies.

1 investor

Theraclion develops ultrasound-based medical devices for non-invasive treatment of vascular and thyroid conditions. The company designs robotic platforms combining ultrasound imaging and robotics for patients seeking alternatives to surgery.

1 investor

TheraDep develops nanoscale plasma coating technology that bonds pharmaceuticals, biologics, and polymers onto surfaces such as metals, plastics, ceramics, and composites at room temperature. Its process targets manufacturers in the labware and medical device markets, offering custom coating solutions that integrate into existing production lines.

1 investor

Theragene Pharmaceuticals develops immunotherapy and gene therapy treatments for cancer and cardiovascular diseases using AAV technology. The company operates in the US and Asia, pursuing partnerships for product development and licensing.

1 investor

Therakos develops THERAKOS Photopheresis, an FDA-approved extracorporeal photopheresis (ECP) system used to treat skin symptoms of cutaneous T-cell lymphoma (CTCL) unresponsive to other treatments. It provides medical devices and associated drug therapy for clinicians treating CTCL patients.

1 investor

TheraNova is a venture studio and incubator that develops medical devices from concept through clinical trials, regulation, and commercialization using a shared R&D model. It creates and spins out privately funded medical device companies and has conducted clinical research in the United States, Europe, and South America.

1 investor

Theratome Bio is a regenerative medicine company using artificial intelligence to develop secretome-based therapeutics that address tissue repair and disease. The company focuses on organ transplant preservation and dry eye disease treatments.

1 investor

THERAtRAME is a biotech company developing tRNA-targeting therapies for cancer patients, particularly those resistant to current treatments. The company translates research on tRNA biology and modifications into first-in-class drug candidates to address therapeutic resistance and tumor progression.

1 investor

Theravance Biopharma develops FDA-approved pharmaceutical treatments, including YUPELRI for chronic obstructive pulmonary disease (COPD) maintenance treatment. The company focuses on delivering innovative medicines that address unmet medical needs.

1 investor

TheraVida is a clinical-stage specialty pharmaceutical company developing combination drug therapies for patients with hyperhidrosis (excessive sweating). Its patent-protected technology aims to improve tolerability over existing treatments while maintaining efficacy.

1 investor

Takeda Pharmaceuticals is a global pharmaceutical company developing medicines and creating new standards of care for patients and communities across therapeutic areas.

1 investor

Theriva Biologics is a clinical-stage company developing therapeutics for cancer and related diseases, including an oncolytic adenovirus platform (VCN-01) and enzyme-based candidates for gastrointestinal and systemic conditions (SYN-004, SYN-020). It is a publicly traded biopharmaceutical company (NYSE American: TOVX) focused on areas of high unmet medical need.

1 investor

Developer of next-generation insulin solutions

1 investor

Therna develops an AI platform that designs and optimizes programmable RNA medicines, including mRNA and antisense oligonucleotide/siRNA therapeutics, using generative AI models informed by proprietary experimental validation data.

1 investor

Theseus Labs develops brain-computer interfaces and publishes neurotechnology research, while building software products for BCI data calibration and neuro-applications. The company also invests in and supports early-stage neurotech startups.

1 investor

Thestra is a University of Turku spin-out developing AI-based cancer diagnostics, including its EPLINEX biomarker assay that estimates tumor aggressiveness in head and neck squamous cell carcinoma (HNSCC) to help clinicians stratify patients to appropriate therapies. Its products serve clinicians and hospitals to guide treatment selection and prognosis.

1 investor